Obsidian Therapeutics
Latest round
- Series C
Last raised
- Apr 2024
Total raised
- $308M
Investors
- 27
About Obsidian Therapeutics
Based in Massachusetts, US, and founded in 2015, Obsidian Therapeutics, Inc. is a biotechnology company dedicated to the development of next-generation cell and gene therapies for the treatment of cancer. In April 2024, Obsidian Therapeutics, Inc.80 million post-money. Obsidian has developed platform technologies that allow for exquisite control of protein activity in cells, thereby enabling tunable cell and gene therapies. The cytoDRiVE® platform supports drug-responsive domains (DRDs) to control protein function using an FDA-approved small molecule. The company is developing a tumor-infiltrating lymphocyte (TIL) program, cytoTIL15, into the clinic and to first clinical data for the treatment of metastatic melanoma.
Who invested in Obsidian Therapeutics
27 investors across 3 rounds
See all investors in Obsidian Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Obsidian Therapeutics
Who invested in Obsidian Therapeutics?
Obsidian Therapeutics has 27 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Obsidian Therapeutics raised?
Obsidian Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Obsidian Therapeutics last raise money?
Obsidian Therapeutics's most recent round on record is a Series C, in Apr 2024.
What does Obsidian Therapeutics do?
Based in Massachusetts, US, and founded in 2015, Obsidian Therapeutics, Inc.
Where is Obsidian Therapeutics headquartered?
Obsidian Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Obsidian Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Obsidian Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Obsidian Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.